Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. News
  7. Summary
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Seagen

06/21/2021 | 06:05pm EDT


ę MT Newswires 2021
All news about SEAGEN INC.
07/16SEAGEN : Morgan Stanley Adjusts Price Target on Seagen to $167 From $173, Mainta..
MT
07/15SEAGEN INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
07/15Seagen Inc. Enters into A Commercial Supply Agreement Hovione FarmaCiencia SA
CI
07/12ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA..
AQ
07/09SEAGEN INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/09Seagen Inc. and Astellas Pharma Inc. Announces the U.S. Food and Drug Adminis..
CI
07/08SEAGEN : to Host Conference Call and Webcast Discussion of Second Quarter 2021 F..
BU
07/06INSIDER TRENDS : 90-Days of Insider Buying at Seagen Eased Back with Share Dispo..
MT
07/05SUN HUNG KAI PROPERTIES : Didi cybersecurity probe blindsides shareholders days ..
RE
07/01FACTBOX : How do ride-hailing giants Didi and Uber compare?
RE
More news
Financials (USD)
Sales 2021 1 490 M - -
Net income 2021 -430 M - -
Net cash 2021 2 337 M - -
P/E ratio 2021 -60,5x
Yield 2021 -
Capitalization 25 955 M 25 955 M -
EV / Sales 2021 15,9x
EV / Sales 2022 10,7x
Nbr of Employees 2 092
Free-Float 99,3%
Chart SEAGEN INC.
Duration : Period :
Seagen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEAGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 143,02 $
Average target price 185,61 $
Spread / Average Target 29,8%
EPS Revisions
Managers and Directors
Clay B. Siegall Chairman, President & Chief Executive Officer
Todd E. Simpson Chief Financial Officer
Vaughn B. Himes Chief Technical Officer
Roger D. Dansey Chief Medical Officer
Marc E. Lippman Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEAGEN INC.-18.34%25 955
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.60%31 265
CUREVAC N.V.-33.14%21 497